Literature DB >> 14531961

The genetics of primary Sjögren's syndrome.

Amr H Sawalha1, Robyn Potts, Wendi R Schmid, R Hal Scofield, John B Harley.   

Abstract

Primary Sjögren's syndrome is an autoimmune disease characterized clinically by dryness of the eyes and mouth. The use of different classification criteria for primary Sjögren's syndrome has led to dramatically different estimates of prevalence and incidence. Despite this, several genetic and environmental factors are thought to play a role in the susceptibility to primary Sjögren's syndrome, as is the current conceptual formulation of the pathogenesis of many other autoimmune maladies. Primary Sjögren's syndrome appears a complicated polygenic disorder with many genes interacting with environmental factors. Similar to many other polygenic autoimmune rheumatic diseases, human leukocyte antigen associations have been reported and confirmed. Additionally, other non-human leukocyte antigen candidate genes have been reported to reveal association with primary Sjögren's syndrome, but, in general, these effects are not confirmed. The authors review the human leukocyte antigen and non-human leukocyte antigen genetic associations herewith, knowing that new technologies are providing access to the entire genome for association studies. No doubt a much more comprehensive description of the genetics of this disorder will soon emerge.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14531961     DOI: 10.1007/s11926-003-0012-x

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.592


  70 in total

1.  Specific amino acid residues in the second hypervariable region of HLA-DQA1 and DQB1 chain genes promote the Ro (SS-A)/La (SS-B) autoantibody responses.

Authors:  J D Reveille; M J Macleod; K Whittington; F C Arnett
Journal:  J Immunol       Date:  1991-06-01       Impact factor: 5.422

2.  Excessive synthesis of matrix metalloproteinases in exocrine tissues of NOD mouse models for Sjögren's syndrome.

Authors:  S Yamachika; J M Nanni; K H Nguyen; L Garces; J M Lowry; C P Robinson; J Brayer; G E Oxford; A da Silveira; M Kerr; A B Peck; M G Humphreys-Beher
Journal:  J Rheumatol       Date:  1998-12       Impact factor: 4.666

3.  Association of the glutathione S-transferase M1 homozygous null genotype with susceptibility to Sjögren's syndrome in Japanese individuals.

Authors:  A Morinobu; S Kanagawa; M Koshiba; S Sugai; S Kumagai
Journal:  Arthritis Rheum       Date:  1999-12

4.  Novel variant of p230 trans-Golgi network protein identified by serum from Sjögren's syndrome patient.

Authors:  Y Tsukada; H Ichikawa; Z Chai; F P Lai; K Dunster; J W Sentry; B H Toh
Journal:  Eur J Cell Biol       Date:  2000-11       Impact factor: 4.492

5.  Elevated levels of cysteine protease activity in saliva and salivary glands of the nonobese diabetic (NOD) mouse model for Sjögren syndrome.

Authors:  C P Robinson; S Yamachika; C E Alford; C Cooper; E L Pichardo; N Shah; A B Peck; M G Humphreys-Beher
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-27       Impact factor: 11.205

6.  HLA class I and class II are both associated with the genetic predisposition to primary Sjögren syndrome.

Authors:  P Loiseau; V Lepage; F Djelal; M Busson; R Tamouza; C Raffoux; C J Menkes; O Meyer; D Charron; D Goldberg
Journal:  Hum Immunol       Date:  2001-07       Impact factor: 2.850

7.  Genetic studies of Ro (SS-A) and La (SS-B) autoantibodies in families with systemic lupus erythematosus and primary Sjögren's syndrome.

Authors:  F C Arnett; R G Hamilton; J D Reveille; W B Bias; J B Harley; M Reichlin
Journal:  Arthritis Rheum       Date:  1989-04

8.  DRB1*15 and DRB1*03 extended haplotype interaction in primary Sjögren's syndrome genetic susceptibility.

Authors:  S Jean; E Quelvennec; M Alizadeh; P Guggenbuhl; B Birebent; A Perdriger; B Grosbois; P Y Pawlotsky; G Semana
Journal:  Clin Exp Rheumatol       Date:  1998 Nov-Dec       Impact factor: 4.473

9.  Prevalence of serum and salivary antibodies to HTLV-1 in Sjögren's syndrome.

Authors:  K Terada; S Katamine; K Eguchi; R Moriuchi; M Kita; H Shimada; I Yamashita; K Iwata; Y Tsuji; S Nagataki
Journal:  Lancet       Date:  1994-10-22       Impact factor: 79.321

Review 10.  The genetics of systemic lupus erythematosus: putting the pieces together.

Authors:  J A Kelly; K L Moser; J B Harley
Journal:  Genes Immun       Date:  2002-10       Impact factor: 2.676

View more
  6 in total

1.  Effects of oral consumption of the green tea polyphenol EGCG in a murine model for human Sjogren's syndrome, an autoimmune disease.

Authors:  Kevin Gillespie; Isamu Kodani; Douglas P Dickinson; Kalu U E Ogbureke; Amy M Camba; Mengjie Wu; Stephen Looney; Tin-Chun Chu; Haiyan Qin; Frederick Bisch; Mohamed Sharawy; George S Schuster; Stephen D Hsu
Journal:  Life Sci       Date:  2008-09-06       Impact factor: 5.037

2.  Mechanisms dependent on tryptophan catabolism regulate immune responses in primary Sjögren's syndrome.

Authors:  M Pertovaara; A Raitala; H Uusitalo; J Pukander; H Helin; S S Oja; M Hurme
Journal:  Clin Exp Immunol       Date:  2005-10       Impact factor: 4.330

3.  Th2 cytokine genotypes are associated with a milder form of primary Sjogren's syndrome.

Authors:  M Pertovaara; J Antonen; M Hurme
Journal:  Ann Rheum Dis       Date:  2005-09-15       Impact factor: 19.103

4.  Functional characterization of the MECP2/IRAK1 lupus risk haplotype in human T cells and a human MECP2 transgenic mouse.

Authors:  Kristi A Koelsch; Ryan Webb; Matlock Jeffries; Mikhail G Dozmorov; Mark Barton Frank; Joel M Guthridge; Judith A James; Jonathan D Wren; Amr H Sawalha
Journal:  J Autoimmun       Date:  2013-02-18       Impact factor: 7.094

Review 5.  Sjögren's syndrome: diagnosis and therapeutic challenges in the elderly.

Authors:  Kristine P Ng; David A Isenberg
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

6.  Tear ATG5 as a Potential Novel Biomarker in the Diagnosis of Sjögren Syndrome.

Authors:  Yong-Soo Byun; Hyun Jung Lee; Soojung Shin; Moon Young Choi; Hyung-Seung Kim; So-Hyang Chung
Journal:  Diagnostics (Basel)       Date:  2021-01-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.